Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Duffaud

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2009
Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trialSébastien Salas, Karine Baumstarck-Barrau, Marc Alfonsi, et al.
Therapeutic Drug Monitoring|August 4, 2006
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasmaSébastien Salas, Cédric Mercier, Joseph Ciccolini, et al.
International Journal of Cancer|May 19, 2009
Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2Sébastien Salas, Pascal Jézéquel, Loic Campion, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2020
CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatmentJean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, et al.
Bulletin Du Cancer|December 6, 2006
[Neoadjuvant chemotherapy in sarcoma]Jean-Yves Blay, Sylvie Bonvalot, Jérôme Fayette, et al.
The Lancet. Oncology|September 25, 2010
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trialAxel Le Cesne, Isabelle Ray-Coquard, Binh Nguyen Bui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapiesJoseph Ciccolini, Laetitia Dahan, Nicolas André, et al.
Bulletin Du Cancer|March 2, 2023
[Uterine leiomyosarcoma - French guidelines from the GSF/NETSARC and TMRG groups]Bérénice Collineau, Catherine Genestie, Sabrina Croce, et al.
The Oncologist|August 4, 2020
High Serum Vitamin B12 Levels Associated with C-Reactive Protein in Older Patients with CancerAnne-Laure Couderc, Eddy Puchades, Patrick Villani, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2006
Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupMichael Leahy, Isabelle Ray-Coquard, Jaap Verweij, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2009
Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trialSébastien Salas, Karine Baumstarck-Barrau, Marc Alfonsi, et al.
Therapeutic Drug Monitoring|August 4, 2006
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasmaSébastien Salas, Cédric Mercier, Joseph Ciccolini, et al.
International Journal of Cancer|May 19, 2009
Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2Sébastien Salas, Pascal Jézéquel, Loic Campion, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2020
CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatmentJean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, et al.
Bulletin Du Cancer|December 6, 2006
[Neoadjuvant chemotherapy in sarcoma]Jean-Yves Blay, Sylvie Bonvalot, Jérôme Fayette, et al.
The Lancet. Oncology|September 25, 2010
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trialAxel Le Cesne, Isabelle Ray-Coquard, Binh Nguyen Bui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapiesJoseph Ciccolini, Laetitia Dahan, Nicolas André, et al.
Bulletin Du Cancer|March 2, 2023
[Uterine leiomyosarcoma - French guidelines from the GSF/NETSARC and TMRG groups]Bérénice Collineau, Catherine Genestie, Sabrina Croce, et al.
The Oncologist|August 4, 2020
High Serum Vitamin B12 Levels Associated with C-Reactive Protein in Older Patients with CancerAnne-Laure Couderc, Eddy Puchades, Patrick Villani, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2006
Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupMichael Leahy, Isabelle Ray-Coquard, Jaap Verweij, et al.
Pageof 14